✦ LIBER ✦

Characterization of vaniprevir, a hepatitis C virus NS3/4A protease inhibitor, in patients with HCV genotype 1 infection: Safety, antiviral activity, resistance, and pharmacokinetics

✍ Scribed by Lawitz, Eric; Sulkowski, Mark; Jacobson, Ira; Kraft, Walter K.; Maliakkal, Benedict; Al-Ibrahim, Mohamed; Gordon, Stuart C.; Kwo, Paul; Rockstroh, Juergen Kurt; Panorchan, Paul; Miller, Michelle; Caro, Luzelena; Barnard, Richard; Hwang, Peggy May; Gress, Jacqueline; Quirk, Erin; Mobashery, Niloufar

Book ID: 123105602
Publisher: Elsevier Science
Year: 2013
Tongue: English
Weight: 367 KB
Volume: 99
Category: Article
ISSN: 0166-3542
DOI: 10.1016/j.antiviral.2013.05.015

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Potency, safety, and pharmacokinetics of

Potency, safety, and pharmacokinetics of the NS3/4A protease inhibitor BI201335 in patients with chronic HCV genotype-1 infection

✍ Michael P. Manns; Marc Bourlière; Yves Benhamou; Stanislas Pol; Maurizio Bonacin 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 767 KB

Naturally occurring hepatitis C virus (H

Naturally occurring hepatitis C virus (HCV) NS3/4A protease inhibitor resistance-related mutations in HCV genotype 1-infected subjects in Italy

✍ Vicenti, I.; Rosi, A.; Saladini, F.; Meini, G.; Pippi, F.; Rossetti, B.; Sidella 📂 Article 📅 2012 🏛 Oxford University Press 🌐 English ⚖ 171 KB

PVI-14 NS3 protease polymorphism and res

PVI-14 NS3 protease polymorphism and resistance profile to protease inhibitors in French patients infected with hepatitis C virus (HCV) genotypes 1 to 5

✍ S. Vallet; F. Viron; H. Le Guillou-Guillemette; C. Henquell; P. Trimoulet; F. Ab 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 44 KB

Danoprevir, an HCV NS3/4A protease inhib

Danoprevir, an HCV NS3/4A protease inhibitor, improves insulin sensitivity in patients with genotype 1 chronic hepatitis C

✍ Moucari, R.; Forestier, N.; Larrey, D.; Guyader, D.; Couzigou, P.; Benhamou, Y.; 📂 Article 📅 2010 🏛 BMJ Publishing Group 🌐 English ⚖ 234 KB

MK-5172, a Selective Inhibitor of Hepati

MK-5172, a Selective Inhibitor of Hepatitis C Virus NS3/4a Protease with Broad Activity across Genotypes and Resistant Variants

✍ Summa, V.; Ludmerer, S. W.; McCauley, J. A.; Fandozzi, C.; Burlein, C.; Claudio, 📂 Article 📅 2012 🏛 American Society for Microbiology 🌐 English ⚖ 403 KB

Natural prevalence of hepatitis C virus

Natural prevalence of hepatitis C virus (HCV) variants resistant to protease and polymerase inhibitors in patients infected with HCV genotype 1 in Tunisia

✍ Aissa Larousse, Jameleddine; Trimoulet, Pascale; Recordon-Pinson, Patricia; Papu 📂 Article 📅 2014 🏛 John Wiley and Sons 🌐 English ⚖ 290 KB